Line 164: | Line 164: | ||
<p> | <p> | ||
Our three Cas13a proteins -Lsh, Lwa and Lbu- were purified thanks to the hard work of <a class="myLink" href="/Team:Munich/Team#Ludwig">Ludwig</a> and <a class="myLink" href="/Team:Munich/Team#Max">Max</a>, who along with <a class="myLink" href="/Team:Munich/Team#Aurore">Aurore's</a> feedback designed and cloned the parts necessary for the addition of the TEV-target-sequence. The purification was performed by them two together with the help of <a class="myLink" href="/Team:Munich/Team#Milica">Milica</a> and <a class="myLink" href="/Team:Munich/Team#Benedikt">Benedikt</a> | Our three Cas13a proteins -Lsh, Lwa and Lbu- were purified thanks to the hard work of <a class="myLink" href="/Team:Munich/Team#Ludwig">Ludwig</a> and <a class="myLink" href="/Team:Munich/Team#Max">Max</a>, who along with <a class="myLink" href="/Team:Munich/Team#Aurore">Aurore's</a> feedback designed and cloned the parts necessary for the addition of the TEV-target-sequence. The purification was performed by them two together with the help of <a class="myLink" href="/Team:Munich/Team#Milica">Milica</a> and <a class="myLink" href="/Team:Munich/Team#Benedikt">Benedikt</a> | ||
+ | </p> | ||
+ | </td> | ||
+ | </tr> | ||
+ | |||
+ | <tr><td colspan=3 align=center valign=center> | ||
+ | <h3>Targets</h3> | ||
+ | <p> | ||
+ | The original idea of using 16s rRNA from <i>E. coli</i> as a target for our initial experiments, along with many other things, came from our supervisor <a class="myLink" href="/Team:Munich/Team#Aurore">Aurore</a>. For the other targets that cover a wider spectrum of pathogens, <a class="myLink" href="/Team:Munich/Team#Dali">Dawafuti</a> was the main responsible for choosing and designing them when needed. The target sequences from viral origin were a kindly given by Killian Vogele, a PhD Student from <a href="#">Prof. Simmels</a> group. Dawafuti and <a class="myLink" href="/Team:Munich/Team#Julian">Julian</a> experimented with the diverse RNA extraction and purification methods for detection with Cas13a. | ||
+ | </p> | ||
+ | </td> | ||
+ | </tr> | ||
+ | |||
+ | <tr><td colspan=3 align=center valign=center> | ||
+ | <h3>Targets</h3> | ||
+ | <p> | ||
+ | The original idea of using 16s rRNA from <i>E. coli</i> as a target for our initial experiments, along with many other things, came from our supervisor <a class="myLink" href="/Team:Munich/Team#Aurore">Aurore</a>. For the other targets that cover a wider spectrum of pathogens, <a class="myLink" href="/Team:Munich/Team#Dali">Dawafuti</a> was the main responsible for choosing and designing them when needed. The target sequences from viral origin were a kindly given by Killian Vogele, a PhD Student from <a href="#">Prof. Simmels</a> group. Dawafuti and <a class="myLink" href="/Team:Munich/Team#Julian">Julian</a> experimented with the diverse RNA extraction and purification methods for detection with Cas13a. | ||
</p> | </p> | ||
</td> | </td> |
Revision as of 11:18, 29 September 2017
| ||||||||||||||||||||||||||||||||||||||||
|